Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5531273 | 6386383 | F | 1 | 5531273-X | 20070601 | 20071113 | 20071127 | EXP | DE-JNJFOC-20070704944 | MGI PHARMA, INC. | 64 | YR | F | N | 98 | KG | 20071121 | MD | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5531273 | 1009214420 | PS | DECITABINE (DECITABINE) LYOPHILIZED POWDER | 2 | INTRAVENOUS | 270 MG, IN 6 WEEK, INTRAVENOUS | Y | U | 21790 | ||
| 5531273 | 1009244593 | C | TAVANIC (LEVOFLOXACIN) UNSPECIFIED | 2 | |||||||
| 5531273 | 1009244594 | C | UNACID (UNACID) | 2 | |||||||
| 5531273 | 1009244595 | C | DIFLUCAN (FLUCONAZOLE) UNSPECIFIED | 2 | |||||||
| 5531273 | 1009244596 | C | INSULIN HUMAN (INSULIN HUMAN) UNSPECIFIED | 2 | |||||||
| 5531273 | 1009244597 | C | CEPHORAL (CEFIXIME) UNSPECIFIED | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5531273 | 1009214420 | MYELODYSPLASTIC SYNDROME |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5531273 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5531273 | DRUG TOXICITY |
| 5531273 | GASTROINTESTINAL HAEMORRHAGE |
| 5531273 | MYALGIA |
| 5531273 | PROCTITIS |
| 5531273 | THROMBOCYTOPENIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5531273 | FGN |
| 5531273 | HP |
| 5531273 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5531273 | 1009214420 | 20070129 | 20070520 |